Allergy Therapeutics stock is traded under the ticker #AGY. Below you can review Allergy Therapeutics stock performance in the past 12 months up to November 2025

Total visits to Allergy Therapeutics's top domains

Understand Allergy Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

allergytherapeutics.com2.2K

bencard.com4K

See more with Sales Intelligence

Avg. visit duration in Allergy Therapeutics's top domains

Analyze Allergy Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

allergytherapeutics.com00:00:44

bencard.com00:00:47

See more with Sales Intelligence

Avg. pageviews on Allergy Therapeutics's top domains

See how Allergy Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

allergytherapeutics.com1.71

bencard.com1.65

See more with Sales Intelligence

Allergy Therapeutics top competitors by domain

Top similar sites in November 2025, ranked by their affinity

recalcine.clCompany NameLaboratorios RecalcineEmployees5001 - 10000HQChileAnnual revenue--Total visits--Health > Health - Other

Top technologies used by Allergy Therapeutics

These are the website technologies, by industry, used by Allergy Therapeutics top domains

Widget (3)

reCAPTCHA

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

Email Services (2)

Microsoft Exchange Online

More Technologies

6

See all

News & Signals from Allergy Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAllergy Therapeutics receives financing of $72.7M.AIM-listed Allergy Therapeutics raises £55m & agrees loan facility.

NewsAllergy Therapeutics attends event 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization (AAAAI/WAO) Joint Congress.Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) is set to present its latest research at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization (AAAAI/WAO) Joint Congress, which is taking place in San Diego from 28 February to 3 March.

NewsAllergy Therapeutics attends event 2025 AAAAI/WAO Congress.Allergy Therapeutics showcases research at 2025 AAAAI/WAO Congress.